What sets us apart from other modifi ed cyclodextrins?
A team of experts dedicated
to moving your product forward.
• Decades of experience in the
pharmaceutical industry developing
parenteral, oral, ophthalmic, nasal and
inhalation formulations with Captisol and
other cyclodextrins
• Recent addition of internal resources
and analytical tools will provide greater
responsiveness for collaborative feasibility
and development programs
• The team can help create your product or
assist in your development, safety studies,
regulatory or manufacturing
• Our team has successfully completed or
assisted with orphan designations and
approvals, preclinical, CMC and clinical
development for ANDA, 505b2
and traditional NDA programs
• Academic or Industry, the Captisol team
is available to discuss your application,
evaluate and potentially participate in your
research project or developing the concept
Ready? Call 858-550-5632 or email
cdinfo@captisol.com
Captisol.com